Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Intersect ENT Inc. (XENT)

25.81   0.03 (0.12%) 05-17 16:00
Open: 25.42 Pre. Close: 25.78
High: 26.46 Low: 25.42
Volume: 329,733 Market Cap: 806M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 26.483 - 26.67 26.67 - 26.815
Low: 25.077 - 25.271 25.271 - 25.423
Close: 25.556 - 25.857 25.857 - 26.091

Technical analysis

as of: 2019-05-17 4:32:41 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 35.63     One year: 40.04
Support: Support1: 24.39    Support2: 20.29
Resistance: Resistance1: 30.50    Resistance2: 34.28
Pivot: 28.98
Moving Average: MA(5): 26.31     MA(20): 29.15
MA(100): 30.27     MA(250): 31.04
MACD: MACD(12,26): -1.28     Signal(9): -0.87
Stochastic oscillator: %K(14,3): 16.48     %D(3): 18.92
RSI: RSI(14): 37.05
52-week: High: 42.95  Low: 24.39  Change(%): -33.3
Average Vol(K): 3-Month: 44390  10-Days: 126781

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
XENT has closed above bottom band by 25.0%. Bollinger Bands are 139.3% wider than normal. The large width of the bands suggest high volatility as compared to XENT's normal range. The bands have been in this wide range for 10 bars. This is a sign that the current trend might continue.

Headline News

Mon, 13 May 2019 08:14:30 Z
Abiomed and Intersect ENT Stumble to Start 2019

Fri, 10 May 2019 17:59:33 Z
2 Winners and 2 Losers in the Med Tech Market This Quarter

Tue, 07 May 2019 22:12:00 Z
Why Glu Mobile, Intersect ENT, and Anheuser-Busch InBev Slumped Today

Tue, 07 May 2019 21:11:02 Z
Notable Tuesday Option Activity: XENT, GS, CRZO

Tue, 07 May 2019 17:13:19 Z
Why Intersect ENT Is Getting Mauled Today

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 31.25
Shares Float (M) 30.29
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -0.760
EPS Est. Current Year -0.610
EPS Est. Next Year -0.390
EPS Est. Next Quarter -0.110
Forward EPS -0.260
Book Value (p.s.) 7.300
PEG Ratio -2.87
Profit Margin -25.28
Operating Margin -27.08
Return on Assets (ttm) -21.2
Return on Equity (ttm) -24.4
Qtrly Rev. Growth 7.9
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -17.11
Levered Free Cash Flow (M) -8.29

Stock Valuations

P/E -33.96
P/E Growth Ratio
P/BV 3.54
P/S 223210032.00
P/CF -47.13

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2014-07-11
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.